SV2002000137A - Productos farmaceuticos beta-carbolina ref n. 29342/36539 el - Google Patents

Productos farmaceuticos beta-carbolina ref n. 29342/36539 el

Info

Publication number
SV2002000137A
SV2002000137A SV2000000137A SV2000000137A SV2002000137A SV 2002000137 A SV2002000137 A SV 2002000137A SV 2000000137 A SV2000000137 A SV 2000000137A SV 2000000137 A SV2000000137 A SV 2000000137A SV 2002000137 A SV2002000137 A SV 2002000137A
Authority
SV
El Salvador
Prior art keywords
carbolina
ref
pharmaceutical products
beta
products beta
Prior art date
Application number
SV2000000137A
Other languages
English (en)
Inventor
Neil Robert Anderson
Kerry John Hartauer
Martha A Kral
Original Assignee
Lilly Icos Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22520112&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SV2002000137(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Icos Llc filed Critical Lilly Icos Llc
Publication of SV2002000137A publication Critical patent/SV2002000137A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Abstract

SE REVELA UN COMPUESTO DE FORMULA ESTRUCTURAL (I) Y SALES DEL MISMO ACEPTABLES FARMACEUTICAMENTE, EN DONDE EL COMPUESTO ESTA EN LA FORMULA PARTICULADA DE DROGA LIBRE.
SV2000000137A 1999-08-03 2000-08-07 Productos farmaceuticos beta-carbolina ref n. 29342/36539 el SV2002000137A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14704899P 1999-08-03 1999-08-03

Publications (1)

Publication Number Publication Date
SV2002000137A true SV2002000137A (es) 2002-06-07

Family

ID=22520112

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2000000137A SV2002000137A (es) 1999-08-03 2000-08-07 Productos farmaceuticos beta-carbolina ref n. 29342/36539 el

Country Status (33)

Country Link
EP (1) EP1200092B1 (es)
JP (1) JP4456788B2 (es)
KR (1) KR20020063842A (es)
CN (2) CN101134019A (es)
AR (1) AR033953A1 (es)
AT (1) ATE264680T1 (es)
AU (1) AU773666B2 (es)
BR (1) BR0012901A (es)
CA (1) CA2380087C (es)
CO (1) CO5200849A1 (es)
CZ (1) CZ300151B6 (es)
DE (1) DE60010089T2 (es)
DK (1) DK1200092T3 (es)
DZ (1) DZ3180A1 (es)
EA (1) EA004302B9 (es)
ES (1) ES2220506T3 (es)
HK (1) HK1044278B (es)
HR (1) HRP20020091B1 (es)
HU (1) HU229443B1 (es)
IL (1) IL147642A0 (es)
MX (1) MXPA02001197A (es)
MY (1) MY125428A (es)
NO (1) NO321602B1 (es)
NZ (1) NZ516613A (es)
PE (1) PE20010480A1 (es)
PL (1) PL199469B1 (es)
PT (1) PT1200092E (es)
SK (1) SK286365B6 (es)
SV (1) SV2002000137A (es)
TW (1) TWI235658B (es)
UA (1) UA71629C2 (es)
WO (1) WO2001008688A2 (es)
ZA (1) ZA200200825B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060093355A (ko) * 1999-08-03 2006-08-24 릴리 아이코스 엘엘씨 베타-카르볼린 약학 조성물
EP1804582A4 (en) * 2004-10-28 2009-12-09 Reddys Lab Ltd Dr POLYMORPH SHAPES OF TADALAFIL
ES2318693T5 (es) * 2006-01-05 2018-10-04 Teva Pharmaceutical Industries Ltd Procedimiento de granulación en húmedo para la preparación de composiciones farmacéuticas de aripiprazol
DE102007028869A1 (de) * 2007-06-22 2008-12-24 Ratiopharm Gmbh Verfahren zur Herstellung eines Arzneimittels enthaltend Tadalafil
MD4009C2 (ro) * 2008-07-15 2010-08-31 Институт Химии Академии Наук Молдовы Utilizarea 1-metil-4-(N-metilaminobutil-4)-β-carbolinei în calitate de remediu antituberculos
DE102009033396A1 (de) 2009-07-16 2011-01-20 Ratiopharm Gmbh Wässrige Lösung und gelatinierte Zusammensetzung umfassend einen Phosphodiesterase-5-Inhibitor sowie diesbezügliche Verfahren und Verwendung
DE102009035211A1 (de) 2009-07-29 2011-02-17 Ratiopharm Gmbh Copräzipitate umfassend einen Phosphodiesterase-5-Inhibitor (PDE-5-Inhibitor) und einen pharmazeutisch verträglichen Trägerstoff, ihre Herstellung und Verwendung
WO2012085927A2 (en) * 2010-12-02 2012-06-28 Mylan Laboratories, Limited Tadalafil compositions
WO2012095151A1 (en) 2010-12-23 2012-07-19 Zaklady Farmaceutyczne Polpharma Sa Solid pharmaceutical dosage forms comprising tadalafil and methods of preparation thereof
WO2012107541A1 (en) 2011-02-10 2012-08-16 Synthon Bv Pharmaceutical composition comprising tadalafil and a cyclodextrin
EP2672959A1 (en) 2011-02-10 2013-12-18 Synthon BV Granulated composition comprising tadalafil and a disintegrant
WO2012107092A1 (en) 2011-02-10 2012-08-16 Synthon Bv Pharmaceutical composition comprising tadalafil and a cyclodextrin
JP5930686B2 (ja) * 2011-12-07 2016-06-08 株式会社トクヤマ 溶解性および安定性の向上した難溶性医薬品原体及びその製造方法
US9871201B2 (en) 2012-03-15 2018-01-16 Merck Patent Gmbh Electronic devices
WO2014003678A1 (en) * 2012-06-28 2014-01-03 Xspray Microparticles Ab Pharmaceutical compositions comprising ambrisentan and solid dispersion particles containing tadalafil
WO2014003677A1 (en) * 2012-06-28 2014-01-03 Xspray Microparticles Ab Pharmaceutical compositions comprising solid dispersion particles containing tadalafil
CN105310984A (zh) * 2014-06-10 2016-02-10 合肥贝霓医药科技有限公司 一种pde5抑制剂的超微粉体及其制备方法
ES2699160T3 (es) * 2014-06-24 2019-02-07 Wooshin Labottach Co Ltd Formulación de película de desintegración oral que contiene tadalafilo y procedimiento de preparación de la misma
WO2016012539A1 (en) 2014-07-23 2016-01-28 Krka, D.D., Novo Mesto A process for the preparation of cgmp-phosphodiesterase inhibitor and oral pharmaceutical formulation comprising tadalafil co-precipitates
JP2016106139A (ja) * 2016-03-07 2016-06-16 株式会社トクヤマ 溶解性および安定性の向上した難溶性医薬品原体及びその製造方法
JP2021509114A (ja) * 2017-12-26 2021-03-18 エフティーエフ ファーマ プライベート リミテッド Ｐｄｅ ｖ阻害剤のための液体経口処方物
DK3510997T3 (da) 2018-01-10 2020-10-12 Gap S A Bløde gelatinekaplser omfattende en suspension af tadalafil
CN110638770B (zh) * 2019-10-25 2022-04-05 株洲千金药业股份有限公司 他达拉非片剂的制备方法及以该方法制得的片剂
WO2023227185A1 (en) 2022-05-27 2023-11-30 Rontis Hellas S.A. Improved pharmaceutical composition containing tadalafil and nanomilling process for the preparation thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618845A (en) * 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
GB9511220D0 (en) * 1995-06-02 1995-07-26 Glaxo Group Ltd Solid dispersions

Also Published As

Publication number Publication date
WO2001008688A2 (en) 2001-02-08
CN101134019A (zh) 2008-03-05
KR20020063842A (ko) 2002-08-05
HRP20020091A2 (en) 2004-02-29
TWI235658B (en) 2005-07-11
DE60010089T2 (de) 2004-10-14
CA2380087A1 (en) 2001-02-08
EA200200119A1 (ru) 2002-06-27
CZ2002387A3 (cs) 2002-10-16
MXPA02001197A (es) 2003-02-12
PL199469B1 (pl) 2008-09-30
EA004302B1 (ru) 2004-02-26
SK286365B6 (sk) 2008-08-05
NO20020531L (no) 2002-04-03
EP1200092B1 (en) 2004-04-21
PT1200092E (pt) 2004-07-30
NZ516613A (en) 2003-08-29
AR033953A1 (es) 2004-01-21
DZ3180A1 (fr) 2001-02-08
HUP0202781A3 (en) 2003-10-28
AU773666B2 (en) 2004-06-03
NO321602B1 (no) 2006-06-12
BR0012901A (pt) 2002-04-16
SK1722002A3 (en) 2002-05-09
CA2380087C (en) 2007-05-01
DK1200092T3 (da) 2004-08-16
HK1044278A1 (en) 2002-10-18
MY125428A (en) 2006-07-31
HRP20020091B1 (en) 2006-02-28
HK1044278B (zh) 2004-10-08
NO20020531D0 (no) 2002-02-01
WO2001008688A3 (en) 2001-08-16
HUP0202781A2 (hu) 2002-12-28
ZA200200825B (en) 2003-04-30
DE60010089D1 (de) 2004-05-27
EP1200092A2 (en) 2002-05-02
AU6508400A (en) 2001-02-19
HU229443B1 (en) 2013-12-30
ES2220506T3 (es) 2004-12-16
CZ300151B6 (cs) 2009-02-25
IL147642A0 (en) 2002-08-14
PL353268A1 (en) 2003-11-03
CO5200849A1 (es) 2002-09-27
UA71629C2 (en) 2004-12-15
CN1377270A (zh) 2002-10-30
PE20010480A1 (es) 2001-05-26
EA004302B9 (ru) 2019-01-31
ATE264680T1 (de) 2004-05-15
JP4456788B2 (ja) 2010-04-28
JP2003505510A (ja) 2003-02-12

Similar Documents

Publication Publication Date Title
SV2002000137A (es) Productos farmaceuticos beta-carbolina ref n. 29342/36539 el
AR035500A1 (es) Uso de clorpromazina y pentamidina para la fabricacion de medicamentos, composicion farmaceutica y paquete farmaceutico que comprenden clorpromazina y pentamidina.
CO5011096A1 (es) Medicamentos que contienen antagonistas del receptor 5-ht3 para el tratamiento de la ibs
BR0015188A (pt) Composições farmacêuticas
DE60325354D1 (de) Topisch anwendbare pharmazeutische zubereitung
AR012614A1 (es) Una composicion farmaceutica para la fabricacion de un medicamento destinado para el tratamiento de una infeccion viral susceptible de tratamientocon interferon alfa, un metodo para la fabricacion de un medicamento, el uso de peg12000-ifn alfa para la fabricacion de un medicamento
HN2000000224A (es) Aminoacidos biciclicos como agentes farmaceuticos
CO5060503A1 (es) Formulaciones farmaceuticas
CY1112361T1 (el) Σκευασματα για αντικαρκινικη θεραπεια που περιεχουν εκτεϊνασκιδινη 743
AR004700A1 (es) 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento
AR033796A1 (es) Composicion farmaceutica
ATE211387T1 (de) Oral 1alpha-hydroxyprevitamin d
IT1252692B (it) Composizione farmaceutica per uso oftalmico contenente un antiinfiammatorio non steroideo ed un decongestionante come principi attivi
MX9300399A (es) Derivados heterotriciclicos.
AR034142A1 (es) Una composicion farmaceutica, metodo para fabricar un medicamento en base a dicha composicion y uso de la composicion
ES2191241T3 (es) Preparaciones farmaceuticas por via oral que comprenden s-(3-hidroxipropil)-l-cisteina.
KR920019365A (ko) 디리트로마이신을 함유하는 약학 제형
UY26329A1 (es) Antagonistas de los receptores de vitronectina
ECSP003551A (es) Complejo farmaceutico
AR023452A1 (es) Utilizacion del osanetant para preparacion de medicamentos utiles en el tratamiento de los trastornos del humor
ES2175153T3 (es) Uso de inhibidores de colinesterasa para la fabricacion de un medicamento para el tratamiento de la xerostomia.
ATE295169T1 (de) Arzneimittel gegen infertilität, die mit endometriose assoziiert ist
ES2118451T3 (es) Preparado medicamentoso oral que contiene diclofenaco sodico y un acido organico.
ES2146200T3 (es) Medicamentos inducidos peritonealmente.
ATE210986T1 (de) Zubereitungen von 1,5-benzodiazepinderivaten mit cck-antagonistischen oder agonistischer wirkung mit enterischem überzug